Providers

Latest News

Naim Alkhouri, MD
Semaglutide Shows Promise for MASH Resolution, Severe Fibrosis: Naim Alkhouri, MD

May 9th 2025

Naim Alkhouri, MD, spoke to the potential for glucagon-like peptide-1 (GLP-1) receptor agonists to transform the treatment landscape for patients with metabolic dysfunction-associated steatohepatitis (MASH) and severe fibrosis.

The authors wanted to better understand the problem of avoidable hospitalizations among people with rheumatoid arthritis. | Image credit: everythingpossible - stock.adobe.com
Rheumatoid Arthritis Linked With Heightened Risk of Avoidable Hospitalizations

May 8th 2025

AJMC
An Assessment of Nurse Practitioner Low-Value Care Use in Primary Care

May 8th 2025

Hospital room | Image Credit: catinsyrup - stock.adobe.com
Uncomplicated UTIs Tied to Greater Hospitalization Risk, Higher Health Care Costs

May 8th 2025

Image provided by NCCN
NCCN Summit Seeks to Build Better Connections Between Oncology and Primary Care

May 7th 2025

More News

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo